0001415889-17-001471.txt : 20170908
0001415889-17-001471.hdr.sgml : 20170908
20170908181434
ACCESSION NUMBER: 0001415889-17-001471
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170907
FILED AS OF DATE: 20170908
DATE AS OF CHANGE: 20170908
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: YANG MICHAEL J.
CENTRAL INDEX KEY: 0001702283
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50768
FILM NUMBER: 171077535
MAIL ADDRESS:
STREET 1: C/O ACADIA PHARMACEUTICALS INC.
STREET 2: 3611 VALLEY CENTRE DRIVE,SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 061376651
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-558-2871
MAIL ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
form4-09082017_030923.xml
X0306
4
2017-09-07
0001070494
ACADIA PHARMACEUTICALS INC
ACAD
0001702283
YANG MICHAEL J.
3611 VALLEY CENTRE DRIVE, SUITE 300
SAN DIEGO
CA
92130
false
true
false
false
EVP AND CCO
Stock Option (right to buy)
35.80
2017-09-07
4
A
0
93750
0
A
2027-09-06
Common Stock
93750
93750
D
25% of the shares subject to the Stock Option vest and become exercisable on September 7, 2018. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.
/s/ Elizabeth Carter, Attorney-in-Fact
2017-09-08